Efficacy and safety of s201086/GLPG1972, an ADAMTS-5 inhibitor, in patients with knee osteoarthritis: roccella, a 52-week, randomized, double-blind, dose-ranging phase 2 study. (April 2021) - Schnitzer, T.J.; Pueyo, M.; Deckx, H.; van der Aar, E.; Bernard, K.; Hatch, S.; van der Stoep, M.; Grankov, S.; Phung, D.; Imbert, O.; Chimits, D.; Muller, K.; et al.